P
G1
| 50% | 70% | 90% | Total |
---|
(a) iDEGES/TbT | | | | |
convergent | 69 | 70 | 83 | 222 |
cyclic | 31 | 30 | 17 | 78 |
(b) iDEGES/edgeR | | | | |
convergent | 86 | 86 | 79 | 251 |
cyclic | 14 | 14 | 21 | 49 |
(c) iDEGES/TDT | | | | |
convergent | 82 | 81 | 84 | 247 |
cyclic | 18 | 19 | 16 | 53 |
(d) iDEGES/DESeq | | | | |
convergent | 99 | 97 | 100 | 296 |
cyclic | 1 | 3 | 0 | 4 |
- The numbers of convergent and non-convergent (cyclic) results of 100 trials under PDEG = 20% are shown: (a) iDEGES/TbT, (b) iDEGES/edgeR, (c) iDEGES/TDT, and (d) iDEGES/DESeq. We defined the trial as ‘convergent’ if potential DEGs estimated in the (NC + 1)th iteration was the same as those in the (NC)th iteration and the number of iteration n required for obtaining the convergent result as NC (NC > = 1). We defined the trial as ‘cyclic’ if potential DEGs estimated in the (i + NP)th iteration were the same as those in the ith iteration and the cycle as NP (NP > = 2).